ID

12498

Descripción

Study documentation part: Adverse event. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Görge, University Hospital of Münster. EudraCT - Nr. 2012-000108-13.

Palabras clave

  1. 24/11/15 24/11/15 -
  2. 24/11/15 24/11/15 - Julian Varghese
Subido en

24 de noviembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Adverse event DRKS00004652

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Adverse event

Adverse event
Descripción

Adverse event

Alias
UMLS CUI-1
C0877248
Adverse event
Descripción

Adverse event

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Start date of adverse event
Descripción

Start date

Tipo de datos

date

Alias
UMLS CUI [1]
C0808070
Serious Adverse Event
Descripción

Serious Adverse Event

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519255
Intensity
Descripción

Symptom intensity

Tipo de datos

text

Alias
UMLS CUI [1]
C0518690
Relation to study medication
Descripción

medication study; Relations

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0869014
Measures taken regarding study medication
Descripción

medication study; Measures

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0079809
Adverse event leading to study discontinuation
Descripción

Adverse Event Caused Study Discontinuation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826233
Adverse event end date
Descripción

Adverse Event End Date

Tipo de datos

date

Alias
UMLS CUI [1]
C2697886
Adverse Event Outcome
Descripción

Adverse Event Outcome

Tipo de datos

text

Alias
UMLS CUI [1]
C1705586

Similar models

Riliva_CRF_EudraCT - Nr. 2012-000108-13- Adverse event

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Adverse event
C0877248 (UMLS CUI-1)
Adverse event
Item
Adverse event
text
C0877248 (UMLS CUI [1])
Start date
Item
Start date of adverse event
date
C0808070 (UMLS CUI [1])
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI [1])
Item
Intensity
text
C0518690 (UMLS CUI [1])
Code List
Intensity
CL Item
slight, no effect on daily activities (e.g, cooking, shopping) (1)
CL Item
moderate, daily activity impaired (2)
CL Item
severe, daily activity not possible (3)
Item
Relation to study medication
text
C0013227 (UMLS CUI [1,1])
C0869014 (UMLS CUI [1,2])
Code List
Relation to study medication
CL Item
no reasonable connection (1)
CL Item
reasonable connection (2)
Item
Measures taken regarding study medication
text
C0013227 (UMLS CUI [1,1])
C0079809 (UMLS CUI [1,2])
Code List
Measures taken regarding study medication
CL Item
none (1)
CL Item
dose reduction (2)
CL Item
dose increase (3)
CL Item
temporarily stopped (4)
CL Item
ultimately stopped (5)
CL Item
unknown (6)
CL Item
not applicable (7)
Adverse Event Caused Study Discontinuation
Item
Adverse event leading to study discontinuation
boolean
C2826233 (UMLS CUI [1])
Adverse Event End Date
Item
Adverse event end date
date
C2697886 (UMLS CUI [1])
Item
Adverse Event Outcome
text
C1705586 (UMLS CUI [1])
Code List
Adverse Event Outcome
CL Item
restored (1)
CL Item
improved (2)
CL Item
still not improved (3)
CL Item
restored with permanent damage (4)
CL Item
death (5)
CL Item
unknown (6)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial